Health2 years ago
Covaxin is safe, well tolerated in the age group of 2-18 years, and Barrat Biotech cites a lancet study-The New Indian Express
To Online desk Bharat Biotech International Limited (BBIL) announced on Friday that its COVID-19 vaccine, covaxin, has proven safe, tolerable and immunogenic in Phase II /...
Recent Comments